[
  {
    "ts": "2025-12-12T09:12:16+00:00",
    "headline": "How the Narrative Surrounding Bristol Myers Squibb Is Shifting After Recent Sector and Policy Updates",
    "summary": "Bristol-Myers Squibb has seen its fair value estimate nudged slightly higher to about $53.55 per share, even as analysts bake in a marginally higher discount rate of roughly 6.96% and a deeper projected revenue decline of around -5.34%. This combination reflects cautious recognition that sector wide underperformance and a potentially less punitive policy backdrop could support a gradual rerating, even while expectations for top line growth remain subdued. Stay tuned to see how investors can...",
    "url": "https://finance.yahoo.com/news/narrative-surrounding-bristol-myers-squibb-091216662.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "4845764a-9e5a-3bf2-b383-6674521e5529",
      "content": {
        "id": "4845764a-9e5a-3bf2-b383-6674521e5529",
        "contentType": "STORY",
        "title": "How the Narrative Surrounding Bristol Myers Squibb Is Shifting After Recent Sector and Policy Updates",
        "description": "",
        "summary": "Bristol-Myers Squibb has seen its fair value estimate nudged slightly higher to about $53.55 per share, even as analysts bake in a marginally higher discount rate of roughly 6.96% and a deeper projected revenue decline of around -5.34%. This combination reflects cautious recognition that sector wide underperformance and a potentially less punitive policy backdrop could support a gradual rerating, even while expectations for top line growth remain subdued. Stay tuned to see how investors can...",
        "pubDate": "2025-12-12T09:12:16Z",
        "displayTime": "2025-12-12T09:12:16Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/isv7n73YBii.eJbbdO3fww--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MRv2ZxXw0SbLt6U2idf4TQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/narrative-surrounding-bristol-myers-squibb-091216662.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/narrative-surrounding-bristol-myers-squibb-091216662.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-12T11:52:00+00:00",
    "headline": "These Stocks Are Moving the Most Today: Broadcom, Oracle, Lululemon, Costco, Netskope, and More",
    "summary": "Broadcom falls after reporting earnings, Oracle extends losses, and Lululemon beats analysts’ estimates for third-quarter earnings and revenue.",
    "url": "https://www.barrons.com/articles/stock-movers-0617089c?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "251a017e-bb00-324b-96b9-8bc921aba146",
      "content": {
        "id": "251a017e-bb00-324b-96b9-8bc921aba146",
        "contentType": "STORY",
        "title": "These Stocks Are Moving the Most Today: Broadcom, Oracle, Lululemon, Costco, Netskope, and More",
        "description": "",
        "summary": "Broadcom falls after reporting earnings, Oracle extends losses, and Lululemon beats analysts’ estimates for third-quarter earnings and revenue.",
        "pubDate": "2025-12-12T11:52:00Z",
        "displayTime": "2025-12-12T11:52:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/251a017e-bb00-324b-96b9-8bc921aba146/these-stocks-are-moving-the.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/415aecaa762f12e76886173ed9515232",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sBbY2hcU926fe12V.8.F.A--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/415aecaa762f12e76886173ed9515232.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ViRsH4QKoWM6oTsuaDPAOg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/415aecaa762f12e76886173ed9515232.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/stock-movers-0617089c?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LULU"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "COST"
            },
            {
              "symbol": "OPAI.PVT"
            },
            {
              "symbol": "ORCL"
            },
            {
              "symbol": "NTSK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-12T13:52:00+00:00",
    "headline": "These Stocks Are Moving the Most Today: Broadcom, Oracle, Tilray, Lululemon, Costco, Netskope, and More",
    "summary": "Broadcom falls after reporting earnings, Oracle extends losses, and Lululemon beats analysts’ estimates for third-quarter earnings and revenue.",
    "url": "https://www.barrons.com/articles/stock-movers-0617089c?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "251a017e-bb00-324b-96b9-8bc921aba146",
      "content": {
        "id": "251a017e-bb00-324b-96b9-8bc921aba146",
        "contentType": "STORY",
        "title": "These Stocks Are Moving the Most Today: Broadcom, Oracle, Tilray, Lululemon, Costco, Netskope, and More",
        "description": "",
        "summary": "Broadcom falls after reporting earnings, Oracle extends losses, and Lululemon beats analysts’ estimates for third-quarter earnings and revenue.",
        "pubDate": "2025-12-12T13:52:00Z",
        "displayTime": "2025-12-12T13:52:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/251a017e-bb00-324b-96b9-8bc921aba146/these-stocks-are-moving-the.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/415aecaa762f12e76886173ed9515232",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sBbY2hcU926fe12V.8.F.A--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/415aecaa762f12e76886173ed9515232.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ViRsH4QKoWM6oTsuaDPAOg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/415aecaa762f12e76886173ed9515232.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/stock-movers-0617089c?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LULU"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "COST"
            },
            {
              "symbol": "OPAI.PVT"
            },
            {
              "symbol": "ORCL"
            },
            {
              "symbol": "TLRY"
            },
            {
              "symbol": "NTSK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-12T14:35:42+00:00",
    "headline": "Roblox downgraded, Lululemon upgraded: Wall Street's top analyst calls",
    "summary": "Roblox downgraded, Lululemon upgraded: Wall Street's top analyst calls",
    "url": "https://finance.yahoo.com/news/roblox-downgraded-lululemon-upgraded-wall-143542896.html",
    "source": "The Fly",
    "provider": "yfinance",
    "raw": {
      "id": "a06d493a-85bf-323b-a89b-f0ed2b535c22",
      "content": {
        "id": "a06d493a-85bf-323b-a89b-f0ed2b535c22",
        "contentType": "STORY",
        "title": "Roblox downgraded, Lululemon upgraded: Wall Street's top analyst calls",
        "description": "",
        "summary": "Roblox downgraded, Lululemon upgraded: Wall Street's top analyst calls",
        "pubDate": "2025-12-12T14:35:42Z",
        "displayTime": "2025-12-12T14:35:42Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec",
          "originalWidth": 1200,
          "originalHeight": 628,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YHTvjvqtNAYBPYViMXYCow--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 1200,
              "height": 628,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J3gfZRz3Jb2im4_aLYVn4g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Fly",
          "url": "https://thefly.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/roblox-downgraded-lululemon-upgraded-wall-143542896.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/roblox-downgraded-lululemon-upgraded-wall-143542896.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LULU"
            },
            {
              "symbol": "BAH"
            },
            {
              "symbol": "C"
            },
            {
              "symbol": "VEEV"
            },
            {
              "symbol": "RBLX"
            },
            {
              "symbol": "RH"
            },
            {
              "symbol": "AAL"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "GE"
            },
            {
              "symbol": "BA"
            },
            {
              "symbol": "PYPL"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "ALGT"
            },
            {
              "symbol": "CIEN"
            },
            {
              "symbol": "CRM"
            },
            {
              "symbol": "LMT"
            },
            {
              "symbol": "GD"
            },
            {
              "symbol": "APPF"
            },
            {
              "symbol": "TYL"
            },
            {
              "symbol": "BMI"
            },
            {
              "symbol": "LHX"
            },
            {
              "symbol": "RTX"
            },
            {
              "symbol": "NOC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-12T14:13:25+00:00",
    "headline": "Here Are Friday’s Top Wall Street Analyst Research Calls: Bristol-Myers Squibb, Citigroup, Lululemon Athletica, PayPal, Roblox, Soundhound AI, and More",
    "summary": "Pre-Market Stock Futures: The futures are trading mixed as we get set to close out a wild and woolly week that saw a touch of just about everything. The Federal Reserve, as expected, cut rates again and indicated that another cut could come in 2026. Oracle Corp. (NASDAQ: ORCL), which has been on fire this ... Here Are Friday’s Top Wall Street Analyst Research Calls: Bristol-Myers Squibb, Citigroup, Lululemon Athletica, PayPal, Roblox, Soundhound AI, and More",
    "url": "https://247wallst.com/investing/2025/12/12/here-are-fridays-top-wall-street-analyst-research-calls-bristol-myers-squibb-citigroup-lululemon-athletica-paypal-roblox-soundhound-ai-and-more/",
    "source": "24/7 Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "9dbe506b-d9e0-3295-ae37-746738ce789c",
      "content": {
        "id": "9dbe506b-d9e0-3295-ae37-746738ce789c",
        "contentType": "STORY",
        "title": "Here Are Friday’s Top Wall Street Analyst Research Calls: Bristol-Myers Squibb, Citigroup, Lululemon Athletica, PayPal, Roblox, Soundhound AI, and More",
        "description": "",
        "summary": "Pre-Market Stock Futures: The futures are trading mixed as we get set to close out a wild and woolly week that saw a touch of just about everything. The Federal Reserve, as expected, cut rates again and indicated that another cut could come in 2026. Oracle Corp. (NASDAQ: ORCL), which has been on fire this ... Here Are Friday’s Top Wall Street Analyst Research Calls: Bristol-Myers Squibb, Citigroup, Lululemon Athletica, PayPal, Roblox, Soundhound AI, and More",
        "pubDate": "2025-12-12T14:13:25Z",
        "displayTime": "2025-12-12T14:13:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/24_7_wall_st__718/74bc60924e76f984dbb62a4d8faf6ff8",
          "originalWidth": 1366,
          "originalHeight": 768,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/28SlD17sAW4WuYCLqrNyeg--~B/aD03Njg7dz0xMzY2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/24_7_wall_st__718/74bc60924e76f984dbb62a4d8faf6ff8.cf.webp",
              "width": 1366,
              "height": 768,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_WgxvwyvOnfgA_auAxWYuw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/74bc60924e76f984dbb62a4d8faf6ff8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "24/7 Wall St.",
          "url": "https://247wallst.com/"
        },
        "canonicalUrl": {
          "url": "https://247wallst.com/investing/2025/12/12/here-are-fridays-top-wall-street-analyst-research-calls-bristol-myers-squibb-citigroup-lululemon-athletica-paypal-roblox-soundhound-ai-and-more/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/friday-top-wall-street-analyst-141325974.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "LULU"
            },
            {
              "symbol": "PYPL"
            },
            {
              "symbol": "SOUN"
            },
            {
              "symbol": "ORCL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-12T14:10:02+00:00",
    "headline": "3 Top Dividend Stocks to Maximize Your Retirement Income",
    "summary": "The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?",
    "url": "https://finance.yahoo.com/news/3-top-dividend-stocks-maximize-141002584.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "b1453bb8-41b7-3973-a400-8c20a11441ac",
      "content": {
        "id": "b1453bb8-41b7-3973-a400-8c20a11441ac",
        "contentType": "STORY",
        "title": "3 Top Dividend Stocks to Maximize Your Retirement Income",
        "description": "",
        "summary": "The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?",
        "pubDate": "2025-12-12T14:10:02Z",
        "displayTime": "2025-12-12T14:10:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248",
          "originalWidth": 900,
          "originalHeight": 467,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EqfP7bv9QEr5Eo0h619oww--~B/aD00Njc7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248.cf.webp",
              "width": 900,
              "height": 467,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vJLygzZiYik0.mXQcVdmSw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-top-dividend-stocks-maximize-141002584.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-top-dividend-stocks-maximize-141002584.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-12T15:35:00+00:00",
    "headline": "The Best Turnaround Stock to Invest $1,000 in Right Now",
    "summary": "Pfizer and Bristol Myers Squibb are deeply out-of-favor drugmakers, but one could be the better turnaround candidate if you think long term.",
    "url": "https://www.fool.com/investing/2025/12/12/the-best-turnaround-stock-to-invest-1000-in-right/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "0f59533b-1d63-3074-888c-8f4d3033df44",
      "content": {
        "id": "0f59533b-1d63-3074-888c-8f4d3033df44",
        "contentType": "STORY",
        "title": "The Best Turnaround Stock to Invest $1,000 in Right Now",
        "description": "",
        "summary": "Pfizer and Bristol Myers Squibb are deeply out-of-favor drugmakers, but one could be the better turnaround candidate if you think long term.",
        "pubDate": "2025-12-12T15:35:00Z",
        "displayTime": "2025-12-12T15:35:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/b47511a233a3647268887a15fa81abd3",
          "originalWidth": 1200,
          "originalHeight": 799,
          "caption": "A die with the words buy, sell, and hold on it sitting next to money.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nROAVHH7jxnTMBHKkEGukg--~B/aD03OTk7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/b47511a233a3647268887a15fa81abd3.cf.webp",
              "width": 1200,
              "height": 799,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/O8FyoDk8MdyUHcAKT3_qLA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/b47511a233a3647268887a15fa81abd3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/12/12/the-best-turnaround-stock-to-invest-1000-in-right/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/best-turnaround-stock-invest-1-153500040.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-12T15:35:00+00:00",
    "headline": "These Stocks Are Moving the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More",
    "summary": "Broadcom falls after reporting earnings, Oracle extends losses, and Lululemon beats analysts’ estimates for third-quarter earnings and revenue.",
    "url": "https://www.barrons.com/articles/stock-movers-0617089c?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "251a017e-bb00-324b-96b9-8bc921aba146",
      "content": {
        "id": "251a017e-bb00-324b-96b9-8bc921aba146",
        "contentType": "STORY",
        "title": "These Stocks Are Moving the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More",
        "description": "",
        "summary": "Broadcom falls after reporting earnings, Oracle extends losses, and Lululemon beats analysts’ estimates for third-quarter earnings and revenue.",
        "pubDate": "2025-12-12T15:35:00Z",
        "displayTime": "2025-12-12T15:35:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/251a017e-bb00-324b-96b9-8bc921aba146/these-stocks-are-moving-the.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/415aecaa762f12e76886173ed9515232",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sBbY2hcU926fe12V.8.F.A--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/415aecaa762f12e76886173ed9515232.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ViRsH4QKoWM6oTsuaDPAOg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/415aecaa762f12e76886173ed9515232.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/stock-movers-0617089c?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LULU"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "OPAI.PVT"
            },
            {
              "symbol": "ORCL"
            },
            {
              "symbol": "TLRY"
            },
            {
              "symbol": "COST"
            },
            {
              "symbol": "NTSK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-12T15:03:00+00:00",
    "headline": "Can MRK's New Drugs & Pipeline Help Navigate the Looming Keytruda LOE?",
    "summary": "Merck leans on a fast-growing pipeline and new product launches to aid long-term growth as Keytruda's 2028 LOE nears.",
    "url": "https://finance.yahoo.com/news/mrks-drugs-pipeline-help-navigate-150300881.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "904af40f-544f-38da-bcdc-fa4f0dda6e03",
      "content": {
        "id": "904af40f-544f-38da-bcdc-fa4f0dda6e03",
        "contentType": "STORY",
        "title": "Can MRK's New Drugs & Pipeline Help Navigate the Looming Keytruda LOE?",
        "description": "",
        "summary": "Merck leans on a fast-growing pipeline and new product launches to aid long-term growth as Keytruda's 2028 LOE nears.",
        "pubDate": "2025-12-12T15:03:00Z",
        "displayTime": "2025-12-12T15:03:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/1b28b8f55ab25205feceb1a2771a2b3a",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RRg0vYpNavphT7S8O9jT7w--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1b28b8f55ab25205feceb1a2771a2b3a.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hIkvgr9e5vaptAEV_vkcVg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1b28b8f55ab25205feceb1a2771a2b3a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mrks-drugs-pipeline-help-navigate-150300881.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mrks-drugs-pipeline-help-navigate-150300881.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "RHHBY"
            },
            {
              "symbol": "RHHVF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-12T18:12:01+00:00",
    "headline": "Is Bristol-Myers Squibb a Value Opportunity After 5.1% Rebound and DCF Outlook?",
    "summary": "If you are wondering whether Bristol-Myers Squibb is quietly becoming a value opportunity or just a classic value trap, you are in the right place to unpack what the current share price is really telling us. The stock has edged up about 5.1% over the last month after a softer year to date, with the price still down 9.8% since January and around 4.5% lower over the past year. This suggests sentiment is shifting but not yet fully recovered. Recently, investors have been focused on...",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-value-opportunity-181201769.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "5d88a8da-94b0-39bc-9501-1d7dc05a6f25",
      "content": {
        "id": "5d88a8da-94b0-39bc-9501-1d7dc05a6f25",
        "contentType": "STORY",
        "title": "Is Bristol-Myers Squibb a Value Opportunity After 5.1% Rebound and DCF Outlook?",
        "description": "",
        "summary": "If you are wondering whether Bristol-Myers Squibb is quietly becoming a value opportunity or just a classic value trap, you are in the right place to unpack what the current share price is really telling us. The stock has edged up about 5.1% over the last month after a softer year to date, with the price still down 9.8% since January and around 4.5% lower over the past year. This suggests sentiment is shifting but not yet fully recovered. Recently, investors have been focused on...",
        "pubDate": "2025-12-12T18:12:01Z",
        "displayTime": "2025-12-12T18:12:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/isv7n73YBii.eJbbdO3fww--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MRv2ZxXw0SbLt6U2idf4TQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-value-opportunity-181201769.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-value-opportunity-181201769.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-12T17:45:50+00:00",
    "headline": "Why Bristol-Myers Squibb (BMY) Stock Is Up Today",
    "summary": "Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) jumped 2.6% in the afternoon session after an analyst at Guggenheim upgraded the company's stock from \"Neutral\" to \"Buy\" and set a new price target of $62.",
    "url": "https://finance.yahoo.com/news/why-bristol-myers-squibb-bmy-174550499.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "3d5a7da0-b995-38e3-8940-6ac82927bf0d",
      "content": {
        "id": "3d5a7da0-b995-38e3-8940-6ac82927bf0d",
        "contentType": "STORY",
        "title": "Why Bristol-Myers Squibb (BMY) Stock Is Up Today",
        "description": "",
        "summary": "Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) jumped 2.6% in the afternoon session after an analyst at Guggenheim upgraded the company's stock from \"Neutral\" to \"Buy\" and set a new price target of $62.",
        "pubDate": "2025-12-12T17:45:50Z",
        "displayTime": "2025-12-12T17:45:50Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/37b3541337ce2b08e582bdc742879f1c",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "BMY Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Gk.7_kJOBQAPS7VxEfLOgw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/37b3541337ce2b08e582bdc742879f1c.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YM1F85oh4xO4w1Qalh6PGw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/37b3541337ce2b08e582bdc742879f1c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-bristol-myers-squibb-bmy-174550499.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-bristol-myers-squibb-bmy-174550499.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-12T17:35:49+00:00",
    "headline": "Why Arcus Biosciences Just Reversed Its 287% Eight-Month Winning Streak",
    "summary": "Arcus Biosciences stock plunged Friday, reversing a nearly 300% gain, after its Gilead Sciences-partnered cancer regimen failed.",
    "url": "https://www.investors.com/news/technology/arcus-biosciences-gilead-sciences-anti-tigit-failure/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "f48bab5e-e66c-3b01-82ca-f0a954928223",
      "content": {
        "id": "f48bab5e-e66c-3b01-82ca-f0a954928223",
        "contentType": "STORY",
        "title": "Why Arcus Biosciences Just Reversed Its 287% Eight-Month Winning Streak",
        "description": "",
        "summary": "Arcus Biosciences stock plunged Friday, reversing a nearly 300% gain, after its Gilead Sciences-partnered cancer regimen failed.",
        "pubDate": "2025-12-12T17:35:49Z",
        "displayTime": "2025-12-12T17:35:49Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/f48bab5e-e66c-3b01-82ca-f0a954928223/why-arcus-biosciences-just.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/c41f2b75ef43110c88cfcb472262eb79",
          "originalWidth": 945,
          "originalHeight": 533,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/shVGxj7bu_u.CpYzNTXRdw--~B/aD01MzM7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/c41f2b75ef43110c88cfcb472262eb79.cf.webp",
              "width": 945,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WU5OlgKO09tNMial_TfFPA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/c41f2b75ef43110c88cfcb472262eb79.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/arcus-biosciences-gilead-sciences-anti-tigit-failure/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RCUS"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-12T15:35:00+00:00",
    "headline": "Can Opdivo's Label Expansions Help Bristol Myers Sustain Its Momentum?",
    "summary": "BMY gets a priority FDA review for Opdivo's use in previously untreated advanced Hodgkin lymphoma, reinforcing its oncology momentum.",
    "url": "https://finance.yahoo.com/news/opdivos-label-expansions-help-bristol-153500551.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "87fbf7da-b540-3ecf-9c31-c4adfc26f140",
      "content": {
        "id": "87fbf7da-b540-3ecf-9c31-c4adfc26f140",
        "contentType": "STORY",
        "title": "Can Opdivo's Label Expansions Help Bristol Myers Sustain Its Momentum?",
        "description": "",
        "summary": "BMY gets a priority FDA review for Opdivo's use in previously untreated advanced Hodgkin lymphoma, reinforcing its oncology momentum.",
        "pubDate": "2025-12-12T15:35:00Z",
        "displayTime": "2025-12-12T15:35:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AZ1NFKr1Arip4UWINeWStw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zL5_evNVQm1N5N.bc6WldQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/opdivos-label-expansions-help-bristol-153500551.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/opdivos-label-expansions-help-bristol-153500551.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "RHHBY"
            },
            {
              "symbol": "RHHVF"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-12T22:45:04+00:00",
    "headline": "Bristol Myers Squibb (BMY) Advances While Market Declines: Some Information for Investors",
    "summary": "Bristol Myers Squibb (BMY) closed the most recent trading day at $52.41, moving +2.36% from the previous trading session.",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-bmy-advances-224504844.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "c9d1516b-f04f-34a0-b680-54998462e4b1",
      "content": {
        "id": "c9d1516b-f04f-34a0-b680-54998462e4b1",
        "contentType": "STORY",
        "title": "Bristol Myers Squibb (BMY) Advances While Market Declines: Some Information for Investors",
        "description": "",
        "summary": "Bristol Myers Squibb (BMY) closed the most recent trading day at $52.41, moving +2.36% from the previous trading session.",
        "pubDate": "2025-12-12T22:45:04Z",
        "displayTime": "2025-12-12T22:45:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/d7dcbe11345e3f8e5e71e6827fe3c4c9",
          "originalWidth": 1000,
          "originalHeight": 754,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ySW4yppQRAB0XpI0aj_Aag--~B/aD03NTQ7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/d7dcbe11345e3f8e5e71e6827fe3c4c9.cf.webp",
              "width": 1000,
              "height": 754,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/y7O9v2FlH8hDflZpTNqGwg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d7dcbe11345e3f8e5e71e6827fe3c4c9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-bmy-advances-224504844.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-bmy-advances-224504844.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^DJI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]